Medical Residents Learning Weight Management Counseling Skills
University of Massachusetts, Worcester · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Albert Einstein College of Medicine · NCT06529666
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 630
- US sites recruiting
- 7
- Study start
- June 10, 2024
- Record last updated
- September 10, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to addresses the lack of weight management training physicians receive during their residency training. The main questions it aims to answer are:
- How affective is the MRWeight curriculum at increasing medical residents weight management counseling (WMC) skills.
- Evaluate residents' adoption of WMC skills in encounters with their patients
- what would be the best way to get residents to adopt the WMC skills Residents in the comparison group will receive a course on obesity and weight management. The residents in the intervention group will have to attend 2 informational sessions and will receive 6 email modules on WMC. Both groups will also take part in 3 assessments over the course of 18 months to see which group has better WMC skills.
Being studied: Didatic Session 1: Core Foundation Course; The 3Ps Program; Didactic session 2; Email reinforcement; PowerPoint of the foundational course
Conditions: Weight Management Counseling
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- All PGY1 residents in participating sites
Inclusion Criteria for participating site
- The program is willing and able to incorporate the MRWeight program into the PGY1 core curriculum.
- The residency director will allow PGY1s to complete surveys and curriculum evaluations online or in class and to complete a standardized assessment of their knowledge and use of WMC, and
- The site will allow inclusion of three successive cohorts of PGY1s to ensure more than a sufficient number of residents to adequately test the effect of the intervention
Recruiting US locations
Stanford University
Palo Alto, CA 94304
Site contact: Kim Chiang, MD · 650-498-9000 · kichiang@stanford.edu
UC Davis
Sacramento, CA 95820
Site contact: Stephany Sanchez, MD · 800-282-3284 · stesanchez@UCDAVIS.EDU
Stony Brook
East Setauket, NY 11733
Site contact: Patricia NG, MD · 631-444-4630 · Patricia.Ng@stonybrookmedicine.edu
Albert Einstein College of Medicine
The Bronx, NY 10467
Site contact: Jing Yu Pan, MD · (718) 920-2273 · jpan1@montefiore.org
Penn State University
Hershey, PA 17033
Site contact: Eliana Hempel, MD · 717-531-5160 · ehempel@pennstatehealth.psu.edu
Temple University
Philadelphia, PA 19140
Site contact: Sharon Herring, MD, MPH · 800-836-7536 · sharon.herring@temple.edu
Houston Methodist
Houston, TX 77030
Site contact: Melina Awar, MD · 713-441-0006 · mawar@houstonmethodist.org
Study contacts (from the official record)
- RAJANI SADASIVAM, PhD · (508) 856-8989 · Rajani.Sadasivam@umassmed.edu
Similar studies in California
All weight loss studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
TIXiMED, Inc.
- Location
- Chula Vista, CA
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
Regeneron Pharmaceuticals
- Location
- Glendale, CA
- Eligibility basics
- Ages 18–65